Literature DB >> 20424626

Glomerular disease: ACEIs with or without corticosteroids in IgA nephropathy?

Frank Eitner, Jürgen Floege.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20424626     DOI： 10.1038/nrneph.2010.31

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  7 in total

1.  Corticosteroids in IgA nephropathy: a randomised controlled trial.

Authors:  C Pozzi; P G Bolasco; G B Fogazzi; S Andrulli; P Altieri; C Ponticelli; F Locatelli
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

2.  Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

Authors:  Carlo Manno; Diletta Domenica Torres; Michele Rossini; Francesco Pesce; Francesco Paolo Schena
Journal:  Nephrol Dial Transplant       Date:  2009-07-23       Impact factor: 5.992

3.  Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.

Authors:  Frank Eitner; Diana Ackermann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  J Nephrol       Date:  2008 May-Jun       Impact factor: 3.902

4.  Remission of proteinuria improves prognosis in IgA nephropathy.

Authors:  Heather N Reich; Stéphan Troyanov; James W Scholey; Daniel C Cattran
Journal:  J Am Soc Nephrol       Date:  2007-10-31       Impact factor: 10.121

5.  Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial.

Authors:  Manuel Praga; Eduardo Gutiérrez; Ester González; Enrique Morales; Eduardo Hernández
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

6.  Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.

Authors:  Jicheng Lv; Hong Zhang; Yuqing Chen; Guangtao Li; Lei Jiang; Ajay K Singh; Haiyan Wang
Journal:  Am J Kidney Dis       Date:  2008-10-19       Impact factor: 8.860

Review 7.  Immune modulating therapy for IgA nephropathy: rationale and evidence.

Authors:  Jürgen Floege; Frank Eitner
Journal:  Semin Nephrol       Date:  2008-01       Impact factor: 5.299
  7 in total
  3 in total

Review 1.  Treatment of IgA nephropathy and Henoch-Schönlein nephritis.

Authors:  Jürgen Floege; John Feehally
Journal:  Nat Rev Nephrol       Date:  2013-04-02       Impact factor: 28.314

Review 2.  Corticosteroids in IgA Nephropathy: Lessons from Recent Studies.

Authors:  Rosanna Coppo
Journal:  J Am Soc Nephrol       Date:  2016-09-26       Impact factor: 10.121

Review 3.  Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy.

Authors:  Mototsugu Tanaka; George Seki; Tomonosuke Someya; Michio Nagata; Toshiro Fujita
Journal:  Clin Dev Immunol       Date:  2011-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.